AWS HealthOmics is a HIPAA-eligible service that fully manages the compute, storage, and workflow engine infrastructure required to run bioinformatics analyses at scale for clinical diagnostics, drug discovery, and agricultural research.
Improper limitation of a pathname to a restricted directory in the linting tools of the AWS HealthOmics MCP Server (aws-healthomics-mcp-server) before version 0.0.36 might allow an actor who can influence the MCP agent to write an actor-controlled content to arbitrary locations outside the intended workflow bundle directory, via directory traversal sequences in the workflow_files input.
To remediate this issue, users should upgrade to version 0.0.36 or later.
References
Configurations
No configuration.
History
17 Jul 2026, 20:17
| Type | Values Removed | Values Added |
|---|---|---|
| New CVE |
Information
Published : 2026-07-17 20:17
Updated : 2026-07-20 17:14
NVD link : CVE-2026-15415
Mitre link : CVE-2026-15415
CVE.ORG link : CVE-2026-15415
JSON object : View
Products Affected
No product.
CWE
CWE-23
Relative Path Traversal
